{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:00:02Z","timestamp":1781949602171,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ccep.2020.11.005","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:01:14Z","timestamp":1610236874000},"page":"63-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diabetes and Endocrine Disorders (Hyperthyroidism\/Hypothyroidism) as Risk Factors for Atrial Fibrillation"],"prefix":"10.1016","volume":"13","author":[{"given":"Satoshi","family":"Higa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Maesato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugako","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Suenari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccep.2020.11.005_bib1","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2020.11.005_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccep.2020.02.009","article-title":"Risk factor management before and after atrial fibrillation ablation","volume":"12","author":"Ariyaratnam","year":"2020","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.ccep.2020.11.005_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc09-0939","article-title":"Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation","volume":"32","author":"Nichols","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ccep.2020.11.005_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","article-title":"Diabetes mellitus, glycemic control, and risk of atrial fibrillation","volume":"25","author":"Dublin","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","article-title":"Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study","volume":"98","author":"Huxley","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2020.11.005_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2012.06.030","article-title":"Type 2 diabetes mellitus and risk of incident atrial fibrillation in women","volume":"60","author":"Schoen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ahj.2013.08.012","article-title":"Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research trial","volume":"166","author":"Latini","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccep.2020.11.005_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/2047487315599892","article-title":"Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study","volume":"23","author":"Pallisgaard","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib10","first-page":"543","article-title":"Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits","volume":"12","author":"Liu","year":"2012","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.ccep.2020.11.005_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1152\/ajpheart.00010.2012","article-title":"Conduction and refractory disorders in the diabetic atrium","volume":"303","author":"Watanabe","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","article-title":"AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat","volume":"19","author":"Kato","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib14","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","article-title":"Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart","volume":"54","author":"Anderson","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5603\/CJ.2013.0010","article-title":"Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits","volume":"20","author":"Fu","year":"2013","journal-title":"Cardiol J"},{"key":"10.1016\/j.ccep.2020.11.005_bib16","first-page":"378","article-title":"Assessment of atrial electromechanical delay and P-wave dispersion in patients with type 2 diabetes mellitus","volume":"67","author":"Demir","year":"2016","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/hrt.2008.148528","article-title":"Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation","volume":"95","author":"De Vos","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2020.11.005_bib18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.amjcard.2010.07.038","article-title":"Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose","volume":"106","author":"Chao","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1536\/ihj.50.627","article-title":"Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart","volume":"50","author":"Otake","year":"2009","journal-title":"Int Heart J"},{"key":"10.1016\/j.ccep.2020.11.005_bib20","first-page":"410","article-title":"Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients","volume":"18","author":"Gu","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cvr\/cvu176","article-title":"Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats","volume":"104","author":"Saito","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ccep.2020.11.005_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2020.11.005_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jdiacomp.2017.09.009","article-title":"Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: nationwide population-based cohort study","volume":"32","author":"Ko","year":"2018","journal-title":"J\u00a0Diabet Complications"},{"key":"10.1016\/j.ccep.2020.11.005_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2011.08.081","article-title":"Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes","volume":"156","author":"Chao","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in\u00a0vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccep.2020.11.005_bib26","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/eci.12754","article-title":"Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients","volume":"47","author":"Chen","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ccep.2020.11.005_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-017-0640-5","article-title":"Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan","volume":"16","author":"Chang","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccep.2020.11.005_bib29","doi-asserted-by":"crossref","first-page":"e0197245","DOI":"10.1371\/journal.pone.0197245","article-title":"Antihyperglycemic drugs use and new-onset atrial fibrillation: a population-based nested case control study","volume":"13","author":"Liou","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ccep.2020.11.005_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 Trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2020.11.005_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.hrthm.2010.10.029","article-title":"Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats","volume":"8","author":"Kume","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2020.11.005_bib32","doi-asserted-by":"crossref","first-page":"317.e11","DOI":"10.1016\/j.amjmed.2017.09.044","article-title":"Sulfonylureas as initial treatment for type 2 diabetes and the risk of severe hypoglycemia","volume":"131","author":"Yu","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12933-019-0909-y","article-title":"Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study","volume":"18","author":"Yun","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccep.2020.11.005_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40618-017-0698-7","article-title":"Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials","volume":"40","author":"Monami","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ccep.2020.11.005_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/2047487318755531","article-title":"Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis","volume":"25","author":"Usman","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/pace.12561","article-title":"Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study","volume":"38","author":"Gr\u00f6nberg","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib38","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/europace\/eux327","article-title":"Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation","volume":"20","author":"Ebert","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2020.11.005_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2796.2002.00955.x","article-title":"Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort","volume":"251","author":"Veglio","year":"2002","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib41","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2020.11.005_bib42","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/europace\/eur131","article-title":"Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus","volume":"13","author":"Gu","year":"2011","journal-title":"Europace"},{"issue":"Suppl 2","key":"10.1016\/j.ccep.2020.11.005_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00059-014-4154-6","article-title":"HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation","volume":"40","author":"Lu","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.ccep.2020.11.005_bib44","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/europace\/euv449","article-title":"High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient","volume":"18","author":"Yang","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2020.11.005_bib45","doi-asserted-by":"crossref","first-page":"e012253","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ccep.2020.11.005_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacep.2019.05.018","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib47","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2019.12.037","article-title":"Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European observational multicentre study)","volume":"125","author":"Creta","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10840-006-9049-x","article-title":"Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus-single center experience","volume":"17","author":"Tang","year":"2006","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2016.03.069","article-title":"Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: who benefits and who does not? Data from the German ablation registry","volume":"214","author":"Bogossian","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ccep.2020.11.005_bib51","doi-asserted-by":"crossref","first-page":"e57893","DOI":"10.1371\/journal.pone.0057893","article-title":"New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study","volume":"8","author":"Selmer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ccep.2020.11.005_bib52","first-page":"157","article-title":"A\u00a0reevaluation of atrial fibrillation in thyrotoxicosis","volume":"31","author":"Agner","year":"1984","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ccep.2020.11.005_bib53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1742-1241.1993.tb09693.x","article-title":"Covert hypothyroidism with weight loss and atrial fibrillation","volume":"47","author":"Siddiqui","year":"1993","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.ccep.2020.11.005_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/hrt.78.6.623a","article-title":"Atrial fibrillation and the thyroid","volume":"78","author":"Wong","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2020.11.005_bib55","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCEP.113.000502","article-title":"Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-291X(03)01420-7","article-title":"Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium","volume":"308","author":"Watanabe","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ccep.2020.11.005_bib57","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1152\/ajpheart.00828.2004","article-title":"Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria","volume":"289","author":"Hu","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib58","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/S0021-9258(18)68584-9","article-title":"Thyroid hormone markedly increases the mRNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart","volume":"263","author":"Rohrer","year":"1988","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ccep.2020.11.005_bib59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.RES.69.2.266","article-title":"Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins","volume":"69","author":"Arai","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ccep.2020.11.005_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.RES.73.2.301","article-title":"Bursting of cardiac sodium channels after acute exposure to 3,5,3'-triiodo-L-thyronine","volume":"73","author":"Dudley","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.ccep.2020.11.005_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1113\/jphysiol.1997.sp021999","article-title":"Thyroid hormone regulates postnatal expression of transient K+ channel isoforms in rat ventricle","volume":"500","author":"Shimoni","year":"1997","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0735-1097(01)01731-4","article-title":"Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes","volume":"39","author":"Chen","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib63","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1210\/jc.2008-0092","article-title":"Activation of electrical triggers of atrial fibrillation in hyperthyroidism","volume":"93","author":"Wustmann","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ccep.2020.11.005_bib64","doi-asserted-by":"crossref","first-page":"e0188473","DOI":"10.1371\/journal.pone.0188473","article-title":"Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling","volume":"12","author":"Lozano-Velasco","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ccep.2020.11.005_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(00)00203-3","article-title":"Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the pro-alpha1(I) collagen gene expression by thyroid hormone receptor","volume":"162","author":"Chen","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ccep.2020.11.005_bib66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","article-title":"Management of atrial fibrillation in the post-thyrotoxic state","volume":"72","author":"Nakazawa","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib67","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2169\/internalmedicine.50.6135","article-title":"Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy","volume":"50","author":"Zhou","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2011.08.026","article-title":"Thyroxine monotherapy without amiodarone enhances atrial fibrillation recurrences in amiodarone-induced hypothyroidism","volume":"152","author":"Huang","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10840-007-9088-y","article-title":"Catheter ablation of atrial fibrillation in patients with hyperthyroidism","volume":"18","author":"Ma","year":"2007","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib70","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1253\/circj.CJ-12-0340","article-title":"Prevalence and influence of hyperthyroidism on the long-term outcome of catheter ablation for drug-refractory atrial fibrillation","volume":"76","author":"Machino","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.ccep.2020.11.005_bib71","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/jce.12140","article-title":"Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: a case-control study","volume":"24","author":"Mikhaylov","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib72","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.amjcard.2015.09.028","article-title":"Impact of free thyroxine on the outcomes of left atrial ablation procedures","volume":"116","author":"Sousa","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib73","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.hrthm.2015.06.004","article-title":"History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation","volume":"12","author":"Wongcharoen","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2020.11.005_bib74","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/CJ.a2016.0029","article-title":"Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis","volume":"23","author":"Wang","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.ccep.2020.11.005_bib75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2016.10.069","article-title":"Insulin-requiring versus noninsulin-requiring diabetes and thromboembolic risk in patients with atrial fibrillation: PREFER in AF","volume":"69","author":"Patti","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2020.11.005_bib76","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/dme.13600","article-title":"Use of non-vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus","volume":"35","author":"Itzhaki Ben Zadok","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.ccep.2020.11.005_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hrthm.2008.10.023","article-title":"Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism","volume":"6","author":"Siu","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2020.11.005_bib78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjmed.2014.07.014","article-title":"History of thyroid disorders in relation to clinical outcomes in atrial fibrillation","volume":"128","author":"Bruere","year":"2015","journal-title":"Am J Med"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918220301180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918220301180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:41:20Z","timestamp":1761802880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918220301180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1877918220301180"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2020.11.005","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and Endocrine Disorders (Hyperthyroidism\/Hypothyroidism) as Risk Factors for Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}